425: Strive & Semler Scientific Merger: Risks & Next Steps

Strive, Inc. and Semler Scientific, Inc. detail risks and regulatory steps for their proposed business combination, including potential dilution and integration challenges.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• This communication, reposted by Strive's Chief Risk Officer Jeff Walton, serves as a cautionary statement regarding forward-looking statements related to the merger.
• Strive plans to file a Registration Statement on Form S-4, which will include an Information Statement of Strive, a Proxy Statement of Semler Scientific, and a Prospectus of Strive, to register Class A common stock to be issued in the transaction.
• Semler Scientific stockholders will receive the definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.
• The filing highlights various risks associated with the merger, including potential termination, failure to meet closing conditions, integration difficulties, and dilution from new share issuance.

Sentiment

Score: 6

Explanation: The filing is neutral to slightly cautious, primarily serving as a legal disclosure of forward-looking statements and associated risks for a proposed merger. While the merger itself could be positive, the document focuses on potential challenges and uncertainties, balancing the overall sentiment.

Positives

• The proposed business combination aims to achieve strategic and financial benefits for the combined company.
• The companies are actively progressing with the necessary regulatory filings for the merger.

Negatives

• The proposed transaction may not close as expected or at all due to unmet conditions.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The transaction may be more expensive or take longer to complete than initially projected.
• Management's attention may be diverted from ongoing business operations and opportunities.
• There is a risk of dilution for existing Strive shareholders due to the issuance of additional Class A common stock.
• Potential for adverse reactions from customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing could negatively impact the transaction.

Risks

• The occurrence of any event, change, or circumstance that could lead to the termination of the merger agreement.
• Failure to receive or satisfy closing conditions on a timely basis or at all, preventing the proposed transaction from closing.
• Potential legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the combined company.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors.
• Diversion of management's attention from ongoing business operations.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed business combination, though these are subject to various risks and uncertainties. The outlook includes successfully integrating the combined businesses and realizing anticipated cost savings and strategic gains, potentially involving Bitcoin treasury strategies. However, there is no assurance that actual results will not differ materially from these projections.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., reposted the communication on X.com on October 24, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.
• Each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations.

Industry Context

The filing indicates Strive's and Semler Scientific's strategic move towards a business combination, with a notable mention of 'Bitcoin treasury strategies' and 'digital assets' as potential areas of risk and opportunity for the combined entity. This suggests an evolving corporate finance landscape where digital assets are being considered for treasury management, aligning with a broader trend of companies exploring alternative asset classes.

Stakeholder Impact

• Shareholders (Strive): Potential dilution due to issuance of new Class A common stock.
• Shareholders (Semler Scientific): Will vote on the proposed transaction and receive Strive Class A common stock if approved.
• Customers: Potential for adverse reactions or changes to business relationships.
• Employees: Potential for changes to employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Form S-4 will include an Information Statement of Strive, a Proxy Statement of Semler Scientific, and a Prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

This filing is a cautionary statement regarding a proposed business combination, emphasizing risks and regulatory steps rather than new financial performance. While the merger itself could be a strategic move, the document highlights significant uncertainties including integration challenges, potential dilution, and market risks. Investors should hold their positions and await the full S-4 filing and definitive proxy statement to thoroughly evaluate the merger terms, financial projections, and the combined entity's strategic rationale before making further investment decisions. The mention of Bitcoin treasury strategies introduces an additional layer of volatility and risk that requires careful assessment.

Keywords

Strive Inc, Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury, Digital Assets, Corporate Governance, Shareholder Approval, Proxy Solicitation